Related Experiment Videos
Retroperitoneal cross pelvic bypass grafts
Summary
This study shows an extraperitoneal retropubic cross iliac artery bypass graft is a safe, effective alternative for high-risk patients. The graft demonstrated good early and three-year patency rates, suggesting superiority over subcutaneous grafts.
Area of Science:
- Vascular Surgery
- Surgical Innovation
- Cardiovascular Procedures
Background:
- High-risk patients often require complex arterial bypass grafting.
- Existing bypass options like aortoiliac, axillofemoral, and subcutaneous femorofemoral bypasses carry specific risks.
- Subcutaneously placed grafts may be vulnerable to trauma and infection.
Purpose of the Study:
- To evaluate the safety and efficacy of an extraperitoneal retropubic cross iliac artery bypass graft.
- To compare this novel approach to established bypass techniques in high-risk individuals.
- To assess the graft's patency rates in the short and medium term.
Main Methods:
- The study involved performing an extraperitoneal retropubic cross iliac artery bypass graft.
- Patient selection focused on individuals deemed high-risk for standard surgical interventions.
- Graft patency was assessed at early follow-up and at three years post-procedure.
Main Results:
- The extraperitoneal retropubic cross iliac artery bypass graft was found to be a safe alternative.
- Early graft patency was observed in 58 out of 61 patients.
- At three years, graft patency was maintained in 40 out of 61 patients.
Conclusions:
- The extraperitoneal retropubic cross iliac artery bypass graft is a viable and safe option for high-risk patients.
- This technique may offer advantages over subcutaneous grafts due to reduced susceptibility to trauma and infection.
- The procedure demonstrates promising long-term patency, supporting its clinical utility.